0.857
Schlusskurs vom Vortag:
$0.80
Offen:
$0.8111
24-Stunden-Volumen:
926.46K
Relative Volume:
0.66
Marktkapitalisierung:
$72.38M
Einnahmen:
$153.73M
Nettoeinkommen (Verlust:
$-106.79M
KGV:
-0.4815
EPS:
-1.78
Netto-Cashflow:
$-115.93M
1W Leistung:
+14.21%
1M Leistung:
+7.00%
6M Leistung:
-56.50%
1J Leistung:
-78.52%
Sutro Biopharma Inc Stock (STRO) Company Profile
Firmenname
Sutro Biopharma Inc
Sektor
Branche
Telefon
650-392-8412
Adresse
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie STRO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
STRO
Sutro Biopharma Inc
|
0.857 | 63.38M | 153.73M | -106.79M | -115.93M | -1.78 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
2025-03-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2025-03-14 | Herabstufung | BofA Securities | Buy → Underperform |
2025-03-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
2025-03-14 | Herabstufung | Wedbush | Outperform → Neutral |
2024-05-08 | Eingeleitet | BofA Securities | Buy |
2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
2023-10-06 | Eingeleitet | Oppenheimer | Outperform |
2023-03-21 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-08-18 | Fortgesetzt | Wells Fargo | Overweight |
2021-06-18 | Eingeleitet | H.C. Wainwright | Buy |
2020-12-03 | Eingeleitet | Stifel | Buy |
2020-09-02 | Eingeleitet | Jefferies | Buy |
2020-07-16 | Eingeleitet | Wells Fargo | Overweight |
2020-01-13 | Eingeleitet | SunTrust | Buy |
2019-10-07 | Eingeleitet | BTIG Research | Buy |
2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
2019-04-29 | Eingeleitet | H.C. Wainwright | Buy |
2018-10-22 | Eingeleitet | JMP Securities | Mkt Outperform |
2018-10-22 | Eingeleitet | Piper Jaffray | Overweight |
2018-10-22 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten
What analysts say about Sutro Biopharma Inc. stockFree Stock Market Return Analysis - jammulinksnews.com
What drives Sutro Biopharma Inc. stock priceExplosive capital gains - jammulinksnews.com
Sutro Biopharma Inc. Stock Analysis and ForecastPhenomenal capital appreciation - jammulinksnews.com
Sutro Biopharma partners with FDA to develop ADC reference materials - Investing.com
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates - The Manila Times
FDA Selects Sutro Biopharma's Revolutionary Platform to Shape Future of Cancer Drug Development - Stock Titan
Is Sutro Biopharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
what makes sutro biopharma inc. stock price move sharplyReal Time Alert Service - Newser
Why Sutro Biopharma Inc. stock attracts strong analyst attentionHigh Return Potential - Newser
How Sutro Biopharma Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser
What makes Sutro Biopharma Inc. stock price move sharplyFree Consultation - Newser
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Vontobel Holding Ltd. Has $33,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma, Inc.(NasdaqGM: STRO) dropped from Russell 2000 Dynamic Index - MarketScreener
Sutro Biopharma Faces NASDAQ Non-Compliance Notice - TipRanks
Sutro Biopharma (NASDAQ:STRO) Upgraded to Overweight at Piper Sandler - Defense World
Sutro Biopharma (STRO) Receives Upgrade to Overweight by Piper S - GuruFocus
Piper Sandler Upgrades Sutro Biopharma to Overweight From Neutral, $2 Price Target - MarketScreener
Sutro Biopharma (STRO) Receives Upgrade with Promising Drug Prospects | STRO Stock News - GuruFocus
Piper Sandler upgrades Sutro Biopharma stock rating on pipeline progress By Investing.com - Investing.com Canada
Bank of America Corp DE Sells 22,894 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Analysts - Defense World
Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight | ST - GuruFocus
Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Position Decreased by Two Sigma Investments LP - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Millennium Management LLC - Defense World
ProShare Advisors LLC Boosts Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Nuveen Asset Management LLC Acquires 124,154 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma names Greg Chow as new CFO - Investing.com
Sutro Biopharma (STRO) Appoints New CFO Greg Chow | STRO Stock N - GuruFocus
Sutro Biopharma names Greg Chow as new CFO By Investing.com - Investing.com Canada
Sutro Biopharma Appoints Greg Chow as Chief Financial Officer - The Manila Times
Sutro Biopharma Strengthens ADC Leadership: New CFO Brings $225M Capital Raising Track Record - Stock Titan
Two Sigma Advisers LP Has $1.01 Million Stock Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Northern Trust Corp Buys 14,492 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):